XML 23 R13.htm IDEA: XBRL DOCUMENT v3.8.0.1
STOCK PLANS AND STOCK-BASED COMPENSATION
9 Months Ended
Dec. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
STOCK PLANS AND STOCK-BASED COMPENSATION
4.
STOCK PLANS AND STOCK-BASED COMPENSATION
 
In July 1998, shareholders of the Company approved the adoption of the 1998 Stock Option Plan ("1998 Plan"). The 1998 Plan was effective October 1998 and expired in October 2008. In addition, in July 2003, shareholders of the Company approved the adoption of the 2003 Stock Option Plan ("2003 Plan"). The 2003 Plan was effective in July 2003 and expired in July 2013. Accordingly, no further option awards may be granted under the 1998 Plan or the 2003 Plan; however, any awards granted prior to their expirations remain outstanding subject to their terms. Each option granted under the 1998 Plan or the 2003 Plan has an exercise price equal to the fair market value of the Company's common stock on the date of the grant, a maximum term of ten years and a vesting period from zero to five years.
 
In July 2017, shareholders of the Company approved the 2017 Equity Incentive Plan ("2017 Plan"). The 2017 Plan provides for the grant of incentive stock options, non-qualified stock options, restricted stock and restricted stock units. The Company has reserved 1,800,000 shares of its common stock for issuance under the 2017 Plan.
 
The following table presents information related to stock options outstanding for the periods shown:
 
   
Nine Months Ended
December 31, 2017
   
Nine Months Ended
December 31, 2016
 
   
Number of
Shares
   
Weighted
Average
Exercise
Price
   
Number of
Shares
   
Weighted
Average
Exercise
Price
 
Balance, beginning of period
   
220,654
   
$
4.74
     
223,654
   
$
4.73
 
Options exercised
   
(41,022
)
   
4.01
     
(3,000
)
   
3.84
 
Expired
   
(33,000
)
   
8.49
     
-
     
-
 
Balance, end of period
   
146,632
   
$
4.10
     
220,654
   
$
4.74
 
 
The following table presents information on stock options outstanding for the periods shown, less estimated forfeitures:
 
   
December 31,
 
   
2017
   
2016
 
Stock options fully vested and expected to vest:
           
Number
   
146,632
     
220,654
 
Weighted average exercise price
 
$
4.10
   
$
4.74
 
Aggregate intrinsic value (1)
 
$
678,000
   
$
630,000
 
Weighted average contractual term of options (years)
   
2.93
     
3.60
 
Stock options fully vested and currently exercisable:
               
Number
   
146,632
     
220,654
 
Weighted average exercise price
 
$
4.10
   
$
4.74
 
Aggregate intrinsic value (1)
 
$
678,000
   
$
630,000
 
Weighted average contractual term of options (years)
   
2.93
     
3.60
 
                 
(1) The aggregate intrinsic value of a stock option in the table above represents the total pre-tax intrinsic value (the amount by which the current market value of the
     underlying stock exceeds the exercise price) that would have been received by the option holders had all option holders exercised. This amount changes based on
     changes in the market value of the Company's stock.
 
 
There was no stock-based compensation expense related to stock options for the nine months ended December 31, 2017 and 2016. As of December 31, 2017, all outstanding stock options were fully vested, and there was no remaining unrecognized compensation expense. The total intrinsic value of stock options exercised was $170,000 and $5,000 for the nine months ended December 31, 2017 and 2016, respectively.
 
The fair value of each stock option granted is estimated on the date of grant using the Black-Scholes stock option valuation model. There were no stock options granted during the nine months ended December 31, 2017 and 2016.